$5.060
+0.364 (+7.20%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TRDA por análisis de gráficos similares
Alphio's TRDA stock price prediction model matches the current Entrada Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.96 (-1.94%). The 1-week path is $4.91 (-2.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Entrada Therapeutics Inc?
Entrada Therapeutics Inc is not a strong buy right now due to significant financial losses and declining revenues. The current price is $5.11, and the company reported a net loss of $42.76 million for Q2 2026, indicating ongoing financial struggles. Additionally, insider selling has increased by 1842.13% over the last month, suggesting a lack of confidence from company insiders. The RSI is at 60.02, indicating a neutral momentum, but the forward P/E ratio is extremely high at 3333.33, reflecting uncertainty about future earnings. The main risk is the company's declining cash reserves, which fell from $295.7 million to $223 million in just six months, indicating tightening operational cash flow.
TRDA cerró en $5.06 el Wednesday, tras subir +7.20%
Entrada Therapeutics Inc (TRDA) last closed at $5.0599999, gaining +7.20%. These facts feed the 1-day and 1-week TRDA price prediction above.
Factores de la previsión
Los factores de la previsión de Entrada Therapeutics Inc (TRDA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TRDA, ordenadas por similitud.
Análisis de estacionalidad de TRDA
Historically the probability of a positive November return for TRDA is 46.51%. January offers the highest probability of a positive month at 50.82%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TRDA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $3.17 | $3.97 | $4.59 | -21.51% |
| Dec 2026 | $3.50 | $3.76 | $4.40 | -25.64% |
En 2026, se proyecta que Entrada Therapeutics Inc (TRDA) oscile entre $3.17 y $4.59.
Previsión mensual de Entrada Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Entrada Therapeutics Inc promedie $3.97, con un mínimo de $3.17 y un máximo de $4.59.
En Dec de 2026, se proyecta que Entrada Therapeutics Inc promedie $3.76, con un mínimo de $3.50 y un máximo de $4.40.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.